Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00516217
Status:
COMPLETED
Last Update Posted:
2016-07-06
First Post:
2007-08-14
Brief Title:
Galiximab in Treating Patients With Relapsed or Refractory Hodgkins Lymphoma
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology